54-Year-old male with hepatic cirrhosis and therapy-associated torsade de pointes tachycardia;54-Jähriger patient mit leberzirrhose und therapiebedingten torsade-de-pointes-tachykardien

Internist

Volumn 52, Issue 4, 2011, Pages 445-450

  Lehmann, M ^a   Bruns, T ^a   Herrmann, A ^a   Fritzenwanger, M ^a   Stallmach, A ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Hepatorenal syndrome; QT interval prolongation; Terlipressin; Torsade de pointes

Indexed keywords

TERLIPRESSIN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; QT PROLONGATION; RESUSCITATION; TORSADE DES POINTES;

HUMANS; LIVER CIRRHOSIS; LYPRESSIN; MALE; MIDDLE AGED; TORSADES DE POINTES; VASOCONSTRICTOR AGENTS;

EID: 79953814009     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-010-2667-5     Document Type: Article

References (9)

1. Feu F, Ruiz del Arbol L, Bañares R et al (1996) Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Gastroenterology 111:1291-1299 (Pubitemid 26362254)
2. Kam PC, Williams S, Yoong FF (2004) Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 59:993-1001 (Pubitemid 39307237)
3. Narahara Y, Kanazawa H, Taki Y et al (2009) Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol 24:1791-1797
4. Ouattara A, Landi M, Le Manach Y et al (2005) Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesiology 102:85-92 (Pubitemid 40082844)
5. Roden DM (2004) Drug-induced prolongation of the QT interval. N Engl J Med 350:1013-1022
6. Salerno F, Gerbes A, Ginès P et al (2007) Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56:1310-1318 (Pubitemid 47300435)
7. Sanyal AJ, Boyer T, Garcia-Tsao G et al (2008) Terlipressin Study Group. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134:1360-1368
8. Triantos CK, Samonakis D, Thalheimer U et al (2010) Terlipressin therapy for renal failure in cirrhosis. Eur J Gastroenterol Hepatol 22:481-486
9. Ürge J, Sincl F, Procházka V, Urbánek K (2008) Terlipressin-induced ventricular arrhythmia. Scand J Gastroenterol 43:1145-1148